This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
0,01192 €
Share price
-33.50%
Change (1 day)
-98.97%
Change (1 year)
Categories
EPS for Athersys (ATHX)
EPS in 2023 (TTM): -2,91 €
According to Athersys's latest financial reports the company's current EPS (TTM) is -2,67 €. In 2022 the company made an earnings per share (EPS) of -5,76 € a decrease over its 2021 EPS that were of -1,84 €.
EPS history for Athersys from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -2,91 € | -49.54% |
| 2022 | -5,76 € | 213.94% |
| 2021 | -1,84 € | 395.24% |
| 2020 | -0,37 € | 44.83% |
| 2019 | -0,26 € | 61.11% |
| 2018 | -0,16 € | -37.93% |
| 2017 | -0,26 € | 70.59% |
| 2016 | -0,15 € | -19.05% |
| 2015 | -0,19 € | -25% |
| 2014 | -0,25 € | -48.15% |
| 2013 | -0,48 € | 10.2% |
| 2012 | -0,43 € | -18.33% |
| 2011 | -0,53 € | -0% |
| 2010 | -0,53 € | -25.93% |
| 2009 | -0,71 € | -15.63% |
| 2008 | -0,85 € | -96.39% |
| 2007 | -23,45 € | -61.05% |
| 2006 | -60,20 € | |
| 2005 | N/A |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | 12,49 € | -567.00% | 🇺🇸 USA |
 | 1,64 € | -161.39% | 🇺🇸 USA |
 | 3,50 € | -231.02% | 🇺🇸 USA |
 | -8,07 € | 201.65% | 🇺🇸 USA |
 | 12,43 € | -564.86% | 🇺🇸 USA |
 | 12,37 € | -562.38% | 🇺🇸 USA |
 | 1,61 € | -160.12% | 🇺🇸 USA |
 | 2,81 € | -204.96% | 🇫🇷 France |